Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

نویسندگان

  • Jonas Hugosson
  • Sigrid Carlsson
  • Gunnar Aus
  • Svante Bergdahl
  • Ali Khatami
  • Pär Lodding
  • Carl-Gustaf Pihl
  • Johan Stranne
  • Erik Holmberg
  • Hans Lilja
چکیده

Department of Urology (Prof J Hugosson MD, S Carlsson MD, G Aus MD, S Bergdahl MD, A Khatami MD, P Lodding MD, J Stranne MD), and Oncology (E Holmberg PhD), Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden; Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy at University of Göteborg, Sweden (C G Pihl MD); Department of Laboratory Medicine, Lund University, University Hospital, Malmö, Sweden (Prof H Lilja MD); and Department of Clinical Laboratories, Urology, and Genitourinary Oncology (H Lilja), Memorial Sloan-Kettering Cancer Center, New York, NY, USA

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PSA Screening in Prostate Cancer

Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...

متن کامل

Randomised prostate cancer screening trial: 20 year follow-up

OBJECTIVE To assess whether screening for prostate cancer reduces prostate cancer specific mortality. DESIGN Population based randomised controlled trial. SETTING Department of Urology, Norrköping, and the South-East Region Prostate Cancer Register. PARTICIPANTS All men aged 50-69 in the city of Norrköping, Sweden, identified in 1987 in the National Population Register (n = 9026). INTER...

متن کامل

Words of wisdom. Re: Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

BACKGROUND Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate. METHODS In December, 1994, 20,000 men born between 1930 and 1944, randoml...

متن کامل

Rural residence and prostate cancer screening with prostate-specific antigen.

Prostate cancer mortality worldwide has recently decreased by 6% after peaking in the 1990s. Based on the recently published results of the European Randomised Study for Screening of Prostate Cancer (which showed a relative prostate cancer mortality reduction of at least 20% by PSA-based population screening) it could be assumed that this decrease is in part due to the implementation of prostat...

متن کامل

Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.

BACKGROUND Prostate cancer (PC) is the most commonly diagnosed non-cutaneous cancer in men and their second or third leading cause of cancer death. Prostate-specific antigen (PSA) testing for PC has been in common practice for more than 20 years. OBJECTIVES A systematic review of the scientific literature was conducted to determine the effectiveness of PSA-based population screening programs ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010